Amundi Purchases 151,945 Shares of UiPath Inc. (NYSE:PATH)

Amundi boosted its position in shares of UiPath Inc. (NYSE:PATH) by 32.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 624,858 shares of the company’s stock after acquiring an additional 151,945 shares during the quarter. Amundi owned 0.11% of UiPath worth $8,392,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Smartleaf Asset Management LLC raised its holdings in shares of UiPath by 88.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,454 shares of the company’s stock valued at $31,000 after purchasing an additional 1,152 shares during the period. First Horizon Advisors Inc. increased its position in UiPath by 47.8% during the fourth quarter. First Horizon Advisors Inc. now owns 2,487 shares of the company’s stock worth $32,000 after buying an additional 804 shares during the last quarter. V Square Quantitative Management LLC increased its position in UiPath by 33.4% during the fourth quarter. V Square Quantitative Management LLC now owns 3,030 shares of the company’s stock worth $39,000 after buying an additional 759 shares during the last quarter. Quarry LP raised its stake in UiPath by 654.4% in the third quarter. Quarry LP now owns 3,146 shares of the company’s stock valued at $40,000 after buying an additional 2,729 shares during the period. Finally, True Wealth Design LLC lifted its position in shares of UiPath by 21,710.0% in the third quarter. True Wealth Design LLC now owns 4,362 shares of the company’s stock valued at $56,000 after buying an additional 4,342 shares during the last quarter. Institutional investors and hedge funds own 62.50% of the company’s stock.

Insider Buying and Selling

In related news, CFO Ashim Gupta sold 47,227 shares of the company’s stock in a transaction on Friday, January 3rd. The stock was sold at an average price of $13.06, for a total transaction of $616,784.62. Following the completion of the sale, the chief financial officer now directly owns 856,538 shares in the company, valued at $11,186,386.28. This represents a 5.23 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CAO Hitesh Ramani sold 25,000 shares of the firm’s stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $13.05, for a total value of $326,250.00. Following the completion of the sale, the chief accounting officer now directly owns 269,421 shares in the company, valued at $3,515,944.05. This trade represents a 8.49 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 22.37% of the stock is currently owned by company insiders.

UiPath Stock Up 8.8 %

Shares of UiPath stock opened at $10.84 on Friday. UiPath Inc. has a 12-month low of $9.50 and a 12-month high of $23.97. The company has a market capitalization of $5.96 billion, a price-to-earnings ratio of -67.78 and a beta of 1.00. The firm’s 50-day moving average price is $13.36 and its two-hundred day moving average price is $13.15.

Analysts Set New Price Targets

A number of research firms recently weighed in on PATH. JPMorgan Chase & Co. boosted their target price on UiPath from $17.00 to $18.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Barclays dropped their price objective on shares of UiPath from $15.00 to $12.00 and set an “equal weight” rating on the stock in a research report on Thursday. Evercore ISI cut their target price on shares of UiPath from $16.00 to $12.00 and set an “in-line” rating for the company in a research note on Thursday. Needham & Company LLC reiterated a “hold” rating on shares of UiPath in a research note on Thursday. Finally, Scotiabank cut their price objective on shares of UiPath from $15.00 to $12.00 and set a “sector perform” rating for the company in a research report on Thursday. Two equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $14.53.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.